|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2004-12-14
|
|
pubmed:abstractText |
Although implanted cardioverter defibrillators (ICDs) effectively treat sustained ventricular tachyarrhythmias, up to 50% of ICD recipients eventually require concomitant antiarrhythmic drug therapy to prevent symptomatic arrhythmia recurrences and hence reduce the number of device therapies.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:Al-KhalidiHussein RHR,
pubmed-author:BorggrefeMartinM,
pubmed-author:BrachmannJohannesJ,
pubmed-author:BrumJose MJM,
pubmed-author:CannomDavid SDS,
pubmed-author:DorianPaulP,
pubmed-author:HohnloserStefan HSH,
pubmed-author:HolroydeMichael JMJ,
pubmed-author:MyerburgRobert JRJ,
pubmed-author:PrattCraig MCM,
pubmed-author:SHock Inhibition Evaluation with azimiLiDe (SHIELD) Investigators,
pubmed-author:SingerIgorI,
pubmed-author:TatlaDaljit SDS,
pubmed-author:van der LaanMichaelM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
14
|
|
pubmed:volume |
110
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3646-54
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15533855-Anti-Arrhythmia Agents,
pubmed-meshheading:15533855-Defibrillators, Implantable,
pubmed-meshheading:15533855-Double-Blind Method,
pubmed-meshheading:15533855-Electric Countershock,
pubmed-meshheading:15533855-Endpoint Determination,
pubmed-meshheading:15533855-Female,
pubmed-meshheading:15533855-Humans,
pubmed-meshheading:15533855-Imidazolidines,
pubmed-meshheading:15533855-Male,
pubmed-meshheading:15533855-Middle Aged,
pubmed-meshheading:15533855-Piperazines,
pubmed-meshheading:15533855-Recurrence,
pubmed-meshheading:15533855-Tachycardia, Ventricular
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.
|
|
pubmed:affiliation |
Division of Cardiology, St. Michael's Hospital, 30 Bond St, Toronto, Ontario M5B 1W8, Canada. dorianp@smh.toronto.on.ca
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
